Comparative Pharmacology
Head-to-head clinical analysis: CORTALONE versus DIFLORASONE DIACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORTALONE versus DIFLORASONE DIACETATE.
CORTALONE vs DIFLORASONE DIACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cortisone is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to suppress inflammation and immune response, and regulate metabolism.
Diflorasone diacetate is a corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive actions. It induces phospholipase A2 inhibitory proteins (lipocortins), thereby controlling the biosynthesis of potent mediators of inflammation like prostaglandins and leukotrienes.
10-40 mg orally once daily in the morning; for acute exacerbations, up to 60 mg/day divided into 2-4 doses.
Apply a thin film to affected skin areas twice daily (every 12 hours). Use the lowest effective strength and duration.
None Documented
None Documented
Terminal elimination half-life is 3-5 hours in patients with normal renal function; prolonged to 12-24 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life of approximately 5.7 hours (range 4.4–7.1 h) after topical application; prolonged in hepatic impairment.
Primarily renal (60-70% as unchanged drug), with 10-20% biliary/fecal.
Primarily renal (≤5% unchanged); extensive hepatic metabolism with biliary/fecal elimination of metabolites; total recovery: ~60% in urine (metabolites), ~30% in feces.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid